muscular dystrophy acetyl-l-carnitine alpha lipoic acid nih & Acetyl L-Carnitine Horbäach Acetyl L Carnitine HCL
Description
10.3892/ijo.2010.885 35
DFW, Da Fonseca-Wollheim Method
Composto de L-Carnitina e leo de Crtamo
While a number of trials having studied agents that may potentially modify CIPN development by targeting the underlying mechanisms, there is as yet insufficient evidence to recommend any specific agent[46]
Immunity 55 , 10671081.e1068 (2022)
